PharmStar Pharmaceuticals, Inc. Closes on New Facility ROCKY MOUNT, NC — (MARKET WIRE) — 05/18/11 — PharmStar Pharmaceuticals, Inc. , (PINKSHEETS: PHAR) (the “Company”), a U.S. drug developer, manufacturer and marketer of the FDA -approved, Over-the-Counter (OTC) liquid pain reliever Aquaprin™, today announced that it has closed a transaction to acquire a new CGMP facility […]